Tumor-host signaling interaction reveals a systemic, age-dependent splenic immune influence on tumor development
暂无分享,去创建一个
Philip Hahnfeldt | Lynn Hlatky | Afshin Beheshti | J. Tyson McDonald | Clare Lamont | P. Hahnfeldt | L. Hlatky | A. Beheshti | J. McDonald | Michael Peluso | Justin Wage | C. Lamont | J. Wage | M. Peluso | Clare Lamont | Afshin Beheshti | J. Tyson McDonald
[1] Kozo Nakamura,et al. Overexpression of the csk gene suppresses tumor metastasis in vivo , 2000, International journal of cancer.
[2] Manuel Serrano,et al. The Hallmarks of Aging , 2013, Cell.
[3] S. Sukumar,et al. HOXA5-Induced Apoptosis in Breast Cancer Cells Is Mediated by Caspases 2 and 8 , 2004, Molecular and Cellular Biology.
[4] F. A. Putt,et al. Histopathologic Technic and Practical Histochemistry , 1954, The Yale Journal of Biology and Medicine.
[5] V. Gorgoulis,et al. The effect of various types of splenectomy on the development of B-16 melanoma in mice. , 1999, Anticancer Research.
[6] M. Kasuga,et al. IFN-alpha prevents the growth of pre-neoplastic lesions and inhibits the development of hepatocellular carcinoma in the rat. , 2003, Carcinogenesis.
[7] J. Ju,et al. Inhibition of autophagy and tumor growth in colon cancer by miR-502 , 2012, Oncogene.
[8] J. Grandis,et al. Constitutive activation of Stat5b contributes to carcinogenesis in vivo. , 2003, Cancer research.
[9] H. Koeffler. Peroxisome proliferator-activated receptor gamma and cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[10] David E. Muench,et al. c-Myc and Cancer Metabolism , 2012, Clinical Cancer Research.
[11] B. Ponder,et al. Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway , 2010, Molecular Cancer.
[12] C. Bradham,et al. p38 MAPK in Development and Cancer , 2006, Cell cycle.
[13] M. Heikenwalder,et al. The unexpected role of lymphotoxin β receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development , 2010, Oncogene.
[14] R. Strieter,et al. CCL19 reduces tumour burden in a model of advanced lung cancer , 2006, British Journal of Cancer.
[15] S. Temin,et al. ASCO Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors. , 2010, Journal of oncology practice.
[16] M. Teitell,et al. ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells , 2009, Proceedings of the National Academy of Sciences.
[17] J. Chan,et al. Deficiency in the nuclear‐related factor erythroid 2 transcription factor (Nrf1) leads to genetic instability , 2012, The FEBS journal.
[18] Scott N. Mueller,et al. Stromal cell contributions to the homeostasis and functionality of the immune system , 2009, Nature Reviews Immunology.
[19] T. Tedder,et al. CHST1 and CHST2 sulfotransferase expression by vascular endothelial cells regulates shear‐resistant leukocyte rolling via l‐selectin , 2001, Journal of leukocyte biology.
[20] R. Hales,et al. The Twist Box Domain Is Required for Twist1-induced Prostate Cancer Metastasis , 2013, Molecular Cancer Research.
[21] D. Bartlett,et al. Understanding how we age: insights into inflammaging , 2013, Longevity & healthspan.
[22] W. Ershler. Why tumors grow more slowly in old people. , 1986, Journal of the National Cancer Institute.
[23] J. Campisi. Aging, cellular senescence, and cancer. , 2013, Annual review of physiology.
[24] Christian Gisselbrecht,et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. , 2007, Blood.
[25] G. Rabinovich,et al. Galectin‐3 negatively regulates the frequency and function of CD4+CD25+Foxp3+ regulatory T cells and influences the course of Leishmania major infection , 2013, European journal of immunology.
[26] Z. Radi,et al. Characterization of Age- and Gender-related Changes in the Spleen and Thymus from Control Cynomolgus Macaques Used in Toxicity Studies , 2008, Toxicologic pathology.
[27] A. Koong,et al. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. , 2004, Cancer research.
[28] J. Pouysségur,et al. Targeting the ERK signaling pathway in cancer therapy , 2006, Annals of medicine.
[29] M. Raffeld,et al. ANXA7 expression represents hormone‐relevant tumor suppression in different cancers , 2007, International journal of cancer.
[30] M. Reed,et al. Aging and angiogenesis. , 2003, Frontiers in bioscience : a journal and virtual library.
[31] L. Sachs,et al. The thyroid hormone receptor β induces DNA damage and premature senescence , 2014, The Journal of cell biology.
[32] Brian Bierie,et al. Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer , 2006, Nature Reviews Cancer.
[33] M. Herridge. NFKBIA Deletion in Glioblastomas , 2011 .
[34] M. Neurath,et al. Transcription factor NFATc2 controls the emergence of colon cancer associated with IL-6-dependent colitis. , 2012, Cancer research.
[35] Daniel G. Anderson,et al. Origins of tumor-associated macrophages and neutrophils , 2012, Proceedings of the National Academy of Sciences.
[36] A. Bielawska,et al. IRF8 regulates acid ceramidase expression to mediate apoptosis and suppresses myelogeneous leukemia. , 2011, Cancer research.
[37] C. Purdie,et al. High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer , 2010, International journal of cancer.
[38] I. Fidler,et al. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. , 2007, Endocrine reviews.
[39] H. Seno,et al. The role of CXCR3 and CXCR4 in colorectal cancer metastasis , 2013, International journal of cancer.
[40] Thomas D. Schmittgen,et al. Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.
[41] G. B. Louis,et al. The role of inflammation in age-related disease , 2013, Aging.
[42] Pei Wang,et al. Effects of small interfering RNAs targeting MAPK1 on gene expression profile in HeLa cells as revealed by microarray analysis , 2008, Cell biology international.
[43] Yinmo Yang,et al. Insulin-Like Growth Factor 1 Receptor Promotes the Growth and Chemoresistance of Pancreatic Cancer , 2013, Digestive Diseases and Sciences.
[44] R. Gibbs,et al. PDX‐1 , 2011, Cancer.
[45] Carla H van Gils,et al. Age-related changes in mammographic density and breast cancer risk. , 2013, American journal of epidemiology.
[46] J. Zha,et al. Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis , 2009, Oncogene.
[47] Marc E. Rothenberg,et al. Regulation of Carcinogenesis by IL-5 and CCL11: A Potential Role for Eosinophils in Tumor Immune Surveillance1 , 2007, The Journal of Immunology.
[48] M. Malaguarnera,et al. The role of immunity in elderly cancer. , 2010, Critical reviews in oncology/hematology.
[49] Irina Klaman,et al. Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. , 2004, International journal of oncology.
[50] Q. Tong,et al. Effects of resistin-like molecule β over-expression on gastric cancer cells in vitro. , 2012, World journal of gastroenterology.
[51] Carlos Caldas,et al. A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer , 2008, Breast Cancer Research.
[52] B. Wei,et al. Interferon Gamma: Friend or Foe? , 2007, Transplantation.
[53] D. Bottaro,et al. Targeting the HGF/Met signaling pathway in cancer therapy , 2012, Expert opinion on therapeutic targets.
[54] J. Massagué,et al. TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. , 2005, Cancer cell.
[55] M. Teixeira,et al. Targeting CCL5 in inflammation , 2013, Expert opinion on therapeutic targets.
[56] Nandita Mitra,et al. Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer , 2009, Nature Genetics.
[57] R. Mentlein,et al. An infernal trio: the chemokine CXCL12 and its receptors CXCR4 and CXCR7 in tumor biology. , 2013, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.
[58] Kun Wu,et al. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. , 2010, Cancer research.
[59] T. Stamey,et al. Elevated expression of inhibin alpha in prostate cancer. , 2004, Journal of Urology.
[60] Xiao-Jun Feng,et al. Expression and prognostic significance of MAP4K4 in lung adenocarcinoma. , 2012, Pathology, research and practice.
[61] D. Dhanasekaran,et al. The gep proto-oncogene Gα12 mediates LPA-stimulated activation of CREB in ovarian cancer cells. , 2014, Cellular signalling.
[62] D. Baker,et al. Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses , 2013, Oncogene.
[63] R. D'Amato,et al. VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients , 2012, Angiogenesis.
[64] Haojie Huang,et al. Oncogenic K-Ras requires activation for enhanced activity , 2014, Oncogene.
[65] J. Hung,et al. Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway. , 2013, Carcinogenesis.
[66] S. Wang,et al. Role of SOCS1 in tumor progression and therapeutic application , 2012, International journal of cancer.
[67] Yinghao Sun,et al. Platelet‐derived growth factor‐BB accelerates prostate cancer growth by promoting the proliferation of mesenchymal stem cells , 2013, Journal of cellular biochemistry.
[68] Xiao-Jun Ma,et al. The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway , 2011, Proceedings of the National Academy of Sciences.
[69] G. Pawelec. Immunosenescence and cancer , 2017, Biogerontology.
[70] P. Allavena,et al. Molecular pathways and targets in cancer-related inflammation , 2010, Annals of medicine.
[71] X. Pivot,et al. Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells. , 2011, Cancer research.
[72] F. Pompei,et al. Cancer suppression at old age. , 2008, Cancer research.
[73] Z. Werb,et al. The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.
[74] T. Billiar,et al. HMGB1: Endogenous Danger Signaling , 2008, Molecular medicine.
[75] Chieh-Yu Liu,et al. Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia. , 2013, Blood.
[76] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[77] Zhiguang Li,et al. Endogenous interleukin-4 promotes tumor development by increasing tumor cell resistance to apoptosis. , 2008, Cancer research.
[78] Bernard Massie,et al. Distinct roles for IFN regulatory factor (IRF)-3 and IRF-7 in the activation of antitumor properties of human macrophages. , 2006, Cancer research.
[79] C. Giacomantonio,et al. Annexin A2 is a novel Cellular Redox Regulatory Protein involved in Tumorigenesis , 2011, Oncotarget.
[80] Christian von Mering,et al. STRING 8—a global view on proteins and their functional interactions in 630 organisms , 2008, Nucleic Acids Res..
[81] W. Paul,et al. Growth factor independence 1 antagonizes a p53-induced DNA damage response pathway in lymphoblastic leukemia. , 2013, Cancer cell.
[82] T. Mekhail,et al. Interleukin-2 in Cancer Therapy , 2000, BioDrugs.
[83] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..
[84] A. Stemmer-Rachamimov,et al. EGFR–STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors , 2014, Oncogene.
[85] C. Franceschi,et al. Inflamm‐aging: An Evolutionary Perspective on Immunosenescence , 2000 .
[86] Matthew J. Davis,et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma , 2012, Nature Genetics.
[87] W. Yang,et al. Structural biology of the cell adhesion protein CD2: from molecular recognition to protein folding and design. , 2003, Current protein & peptide science.
[88] P. Hahnfeldt,et al. Proton Irradiation Augments the Suppression of Tumor Progression Observed with Advanced Age , 2014, Radiation research.
[89] Yingxia Liu,et al. EIF4E over-expresses and enhances cell proliferation and cell cycle progression in nasopharyngeal carcinoma , 2013, Medical Oncology.
[90] Jennifer L Owens,et al. STAT6 expression in glioblastoma promotes invasive growth , 2011, BMC Cancer.
[91] Gavin Thurston,et al. Age-Related Changes in Vascular Endothelial Growth Factor Dependency and Angiopoietin-1–Induced Plasticity of Adult Blood Vessels , 2004, Circulation research.
[92] A. Thompson,et al. NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity , 2012, British Journal of Cancer.
[93] K. Khazaie,et al. Tumor STAT1 Transcription Factor Activity Enhances Breast Tumor Growth and Immune Suppression Mediated by Myeloid-derived Suppressor Cells* , 2013, The Journal of Biological Chemistry.
[94] H. Taguchi,et al. Effects of GM-CSF and M-CSF on tumor progression of lung cancer: roles of MEK1/ERK and AKT/PKB pathways. , 2006, International journal of molecular medicine.
[95] J. Abbruzzese,et al. Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma. , 2001, Cancer research.
[96] A. Bajo,et al. Vasoactive intestinal peptide induces oxidative stress and suppresses metastatic potential in human clear cell renal cell carcinoma , 2013, Molecular and Cellular Endocrinology.
[97] M. Kanamori,et al. Expression profile of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancer , 2002, Journal of Cancer Research and Clinical Oncology.
[98] P. Dawson,et al. Enhanced tumor growth in the NaS1 sulfate transporter null mouse , 2010, Cancer science.
[99] Liang Cheng,et al. FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion. , 2011, Cancer research.
[100] Cheng Li,et al. Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.
[101] V. Giguère,et al. Transcriptional control of the ERBB2 amplicon by ERRalpha and PGC-1beta promotes mammary gland tumorigenesis. , 2010, Cancer research.
[102] H. Ding,et al. Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation , 2013, Oncogene.
[103] R. Mebius,et al. Structure and function of the spleen , 2005, Nature Reviews Immunology.
[104] D. Besselsen,et al. Interferon gamma and antisense transforming growth factor beta transgenes synergize to enhance the immunogenicity of a murine mammary carcinoma. , 1999, Cancer immunology, immunotherapy : CII.
[105] Philip Hahnfeldt,et al. Host age is a systemic regulator of gene expression impacting cancer progression. , 2015, Cancer research.
[106] P. Hahnfeldt,et al. Age and Space Irradiation Modulate Tumor Progression: Implications for Carcinogenesis Risk , 2013, Radiation research.
[107] C. Munaut,et al. C1q as a unique player in angiogenesis with therapeutic implication in wound healing , 2014, Proceedings of the National Academy of Sciences.
[108] J. Ochando,et al. Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. , 2012, Cell reports.
[109] S. Chaudhuri,et al. CD2-SLFA3/T11TS interaction facilitates immune activation and glioma regression by apoptosis , 2004, Cancer biology & therapy.
[110] Abass Alavi,et al. Assessment of age-related changes in abdominal organ structure and function with computed tomography and positron emission tomography. , 2007, Seminars in nuclear medicine.
[111] David W. Johnson,et al. Patient samples of renal cell carcinoma show reduced expression of TRAF1 compared with normal kidney and functional studies in vitro indicate TRAF1 promotes apoptosis: potential for targeted therapy , 2012, Pathology.
[112] A. Tsirigos,et al. Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: Similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling" , 2010, Aging.
[113] A. Chariot. The NF-kappaB-independent functions of IKK subunits in immunity and cancer. , 2009, Trends in cell biology.
[114] Craig Murdoch,et al. The role of myeloid cells in the promotion of tumour angiogenesis , 2008, Nature Reviews Cancer.
[115] P. Furth,et al. Loss of Stat5a delays mammary cancer progression in a mouse model , 2002, Oncogene.
[116] P. Dentelli,et al. IL-3 is a novel target to interfere with tumor vasculature , 2011, Oncogene.
[117] C. Denny,et al. Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers. , 2006, Cancer cell.
[118] M. K. Hibbard,et al. PLAG1 fusion oncogenes in lipoblastoma. , 2000, Cancer research.
[119] M. Barcellos-Hoff,et al. Consequences of Epithelial or Stromal TGFβ1 Depletion in the Mammary Gland , 2011, Journal of Mammary Gland Biology and Neoplasia.
[120] Kelly J. Gauger,et al. Tumour supressor secreted frizzled related protein 1 regulates p53‐mediated apoptosis , 2014, Cell biology international.
[121] E. Prakash,et al. Connective tissue growth factor (CTGF) and cancer progression. , 2008, Journal of biomedical science.
[122] K. Mimori,et al. TGM2 Is a Novel Marker for Prognosis and Therapeutic Target in Colorectal Cancer , 2010, Annals of Surgical Oncology.
[123] A. Buzyn,et al. FADD adaptor in cancer , 2005, Medical immunology.
[124] E. White,et al. BAX and BAK mediate p53-independent suppression of tumorigenesis. , 2002, Cancer cell.
[125] S. Nedvetzki,et al. CD44 in Cancer , 2002, Critical reviews in clinical laboratory sciences.
[126] X. Chen,et al. Genes Regulated by Nkx2-3 in Sporadic and Inflammatory Bowel Disease-Associated Colorectal Cancer Cell Lines , 2010, Digestive Diseases and Sciences.
[127] S. Nutt,et al. Oncogenes and Tumor Suppressors (795 articles) Plenary Papers (356 articles) , 2004 .
[128] S. Mocellin,et al. TNF and cancer: the two sides of the coin. , 2008, Frontiers in bioscience : a journal and virtual library.
[129] H. Nomiyama,et al. Molecular Cloning of a Novel Human CC Chemokine EBI1-ligand Chemokine That Is a Specific Functional Ligand for EBI1, CCR7* , 1997, The Journal of Biological Chemistry.
[130] M. Cesta. Normal Structure, Function, and Histology of the Spleen , 2006, Toxicologic pathology.
[131] Andrew H. Beck,et al. CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis. , 2011, The American journal of pathology.
[132] J. Yun,et al. Tumor-Educated Tolerogenic Dendritic Cells Induce CD3ε Down-Regulation and Apoptosis of T Cells through Oxygen-Dependent Pathways1 , 2008, The Journal of Immunology.
[133] J. Sanderson,et al. Immunohistochemical analysis of ageing human B and T cell populations reveals an age-related decline of CD8 T cells in spleen but not gut-associated lymphoid tissue (GALT) , 2000, Mechanisms of Ageing and Development.
[134] B. Carnes,et al. Mortality of Atomic Bomb Survivors Predicted from Laboratory Animals , 2003, Radiation research.
[135] Xin-yang Wang,et al. Upregulation of human DNA binding protein A (dbpA) in gastric cancer cells , 2009, Acta Pharmacologica Sinica.
[136] S. Thorgeirsson,et al. Genomic modeling of tumor onset and progression in a mouse model of aggressive human liver cancer. , 2011, Carcinogenesis.
[137] M. Wicha,et al. Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population. , 2012, Molecular cell.
[138] T. Mak,et al. The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey , 2008, Oncogene.
[139] J. Jorcano,et al. Increased IKKα Expression in the Basal Layer of the Epidermis of Transgenic Mice Enhances the Malignant Potential of Skin Tumors , 2011, PloS one.
[140] E. Reinherz,et al. CD2 engagement induces dendritic cell activation: implications for immune surveillance and T-cell activation. , 2003, Blood.
[141] P. Puigserver,et al. PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis. , 2011, Cancer research.
[142] M. Pittet,et al. The spleen in local and systemic regulation of immunity. , 2013, Immunity.
[143] Kun Zhang,et al. S100A6 Protein Negatively Regulates CacyBP/SIP-Mediated Inhibition of Gastric Cancer Cell Proliferation and Tumorigenesis , 2012, PloS one.
[144] R. Medzhitov,et al. Toll-like receptors and cancer , 2009, Nature Reviews Cancer.
[145] L. Buscail,et al. Targeting miR-21 for the therapy of pancreatic cancer. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[146] A. Seluanov,et al. Changes in DNA repair during aging , 2007, Nucleic acids research.
[147] D. Lewis,et al. A new paradigm for the role of aging in the development of skin cancer. , 2009, The Journal of investigative dermatology.
[148] Z. Cai,et al. Down-regulation of TCF21 is associated with poor survival in clear cell renal cell carcinoma. , 2012, Neoplasma.
[149] A. Koong,et al. XBP1 Is Essential for Survival under Hypoxic Conditions and Is Required for Tumor Growth , 2004, Cancer Research.
[150] W. Liang,et al. TM4 microarray software suite. , 2006, Methods in enzymology.
[151] Chun-Yin Huang,et al. CCL5 increases lung cancer migration via PI3K, Akt and NF-kappaB pathways. , 2009, Biochemical pharmacology.
[152] Robin L. Anderson,et al. Oncostatin m promotes mammary tumor metastasis to bone and osteolytic bone degradation. , 2012, Genes & cancer.
[153] S. Duensing,et al. FGF-2 disrupts mitotic stability in prostate cancer through the intracellular trafficking protein CEP57. , 2013, Cancer research.
[154] Robert Clarke,et al. Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis. , 2005, Carcinogenesis.
[155] R. Jerala,et al. Toll-Like Receptor 4 Activation in Cancer Progression and Therapy , 2011, Clinical & developmental immunology.
[156] Hua-mei Tang,et al. Screening of new tumor suppressor genes in sporadic colorectal cancer patients. , 2008, Hepato-gastroenterology.
[157] J. Campisi. Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors , 2005, Cell.
[158] R. E. Schwarz,et al. Effects of splenectomy on the development of tumor-specific immunity. , 1990, The Journal of surgical research.
[159] H. Frierson,et al. CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated , 2012, Proceedings of the National Academy of Sciences.
[160] J. Bertram,et al. Establishment of a cloned line of Lewis Lung Carcinoma cells adapted to cell culture. , 1980, Cancer letters.
[161] Y. Shyr,et al. PPM1A is a RelA phosphatase with tumor suppressor-like activity , 2014, Oncogene.
[162] Wei Wei,et al. Genetic deficiency of complement isoforms C4A or C4B predicts improved survival of metastatic renal cell carcinoma. , 2009, The Journal of urology.
[163] D. Carbone,et al. Resuscitating cancer immunosurveillance: selective stimulation of DLL1-Notch signaling in T cells rescues T-cell function and inhibits tumor growth. , 2011, Cancer research.
[164] D. Männel,et al. Tumor necrosis factor induces tumor necrosis via tumor necrosis factor receptor type 1-expressing endothelial cells of the tumor vasculature. , 2000, The American journal of pathology.
[165] C. Garrido,et al. Implication of Heat Shock Factors in Tumorigenesis: Therapeutical Potential , 2011, Cancers.